European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.

Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results.

The Mayor of London has launched a new nightlife taskforce which will be led by fabric nightclub founder Cameron Leslie - it will be advising on the future of nightlife in the capital ...

Wellnex is undertaking a $16 million capital raising ahead of a dual listing on London's AIM exchange, a focal point for European expansion.

Vaxxas, a clinical-stage biotechnology company, today announced the appointments of three globally respected vaccine experts as advisors to its product development and strategy team as the company ...

GSK forecast sales in 2025 to grow 3%-5% and reported better-than-expected fourth-quarter earnings, as strength in its HIV ...

Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once ...

GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 ...

Q4 2024Management ViewCEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over ...

Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their use.

European markets are expected to open in negative territory on Wednesday, with investors looking ahead to more earnings from ...